Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors
- 1 January 2005
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 18 (1) , 48-57
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Observer Variation of Lesions of the ThyroidAmerican Journal of Surgical Pathology, 2003
- Observer Variation of Encapsulated Follicular Lesions of the Thyroid GlandAmerican Journal of Surgical Pathology, 2002
- Gene expression in papillary thyroid carcinoma reveals highly consistent profilesProceedings of the National Academy of Sciences, 2001
- Galectin-3 as a Presurgical Immunocytodiagnostic Marker of Minimally Invasive Follicular Thyroid CarcinomaThe Journal of Clinical Endocrinology & Metabolism, 2001
- Galectin-3 and CD44v6 Isoforms in the Preoperative Evaluation of Thyroid NodulesJournal of Clinical Oncology, 1999
- Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasmsCancer, 1999
- MSG1(Melanocyte-Specific Gene 1): Mapping to Chromosome Xq13.1, Genomic Organization, and Promoter AnalysisGenomics, 1998
- Thyroid carcinoma distinctively expresses intracellular fibronectin in vivoCancer Letters, 1997
- GALECTIN-3 AND LAMININ EXPRESSION IN NEOPLASTIC AND NON-NEOPLASTIC THYROID TISSUEThe Journal of Pathology, 1997
- Immunohistochemical Studies on the Localization of Fibronectin in Human Thyroid Neoplastic Tissues.Endocrinologia Japonica, 1988